SCHEMBL1907237

SCHEMBL1907237

Cc1ccccc1C(=S)c1ccc(Nc2ccc(Br)cc2)cc1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 11/20 0.59
MAPK13 O15264 10/20 0.59
MAPK12 P53778 10/20 0.59
MAPK11 Q15759 10/20 0.59
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
LMNA P02545 2/20 0.42
ALDH1A1 P00352 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
RAPGEF4 Q8WZA2 1/20 0.41
DHODH Q02127 1/20 0.40
MAPT P10636 4/20 0.39
KDM4E B2RXH2 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
POLB P06746 1/20 0.38
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1901734 0.91 MAPK14 (0.71) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL1907388 0.90 MAPK14 (0.56) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL1899616 0.89 MAPK14 (0.61) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL1908054 0.88 MAPK14 (0.61) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL1907313 0.88 MAPK14 (0.61) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL5173361 0.87 MAPK14 (0.62) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7033588 0.86 MAPK14 (0.57) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7520113 0.86 MAPK14 (0.49) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL5174045 0.85 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL1907094 0.85 MAPK14 (0.58) MAPK14MAPK13MAPK12MAPK11MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4684515-B2 2011-05-18 JP claimed
US-6541670-B2 Antiinflammatory agents LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-01 US claimed
US-20030013770-A1 Aminobenzophenones as inhibitors of il 1b and tnf LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-01-16 US claimed
EP-1237845-B1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMA AS (DK) 2007-05-23 EP disclosed
US-6541670-B2 Antiinflammatory agents LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-01 US disclosed
US-20030013770-A1 Aminobenzophenones as inhibitors of il 1b and tnf LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013770-A1 Aminobenzophenones as inhibitors of il 1b and tnf IL1B, IL1A, IL6 MAPK14 1553/4885MAPK13 2221/4885MAPK12 1892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.